Scientists have discovered new chronic kidney disease treatment options in 2025-2026, from finerenone for non-diabetic CKD to ...

The Global Non-Alcoholic Steatohepatitis Treatment Market is entering its first sustained commercial expansion phase as ...

Eli Lilly has agreed to buy a Peter Thiel-backed psychedelic drug developer for up to $3.8bn, as the world’s most valuable ...

Novo Nordisk is relying on first-mover advantage in the obesity pill arena to close the gap on Eli Lilly.

Both lifestyle and genetics are critical markers for cardiac health However one may outweigh the other in some cases Read ...

Blood tests for tau, a key biomarker of Alzheimer’s disease, may predict dementia risk, a new study found. How best to use ...

Strong U.S. demand and new product launches drive first-half sales in Human PharmaNet sales reach EUR 15.8 billion, led by JARDIANCE® and ...

Vanda Pharma cash could be depleted by the end of 2027; multiple pipeline bets heighten both risk and opportunity. Read my ...

Vogenx has joined the growing queue for the Nasdaq, as the metabolic biotech eyes an IPO to fund its SGLT1 inhibitor. | ...

Sonali Bendre’s 18–20-hour fasting routine has revived debate around intermittent fasting and autophagy. Doctors say longer fasting windows are not a universal fix and must be assessed against ...

Novo Nordisk presents positive results from phase 3 FRONTIER4 extension study of denecimig subcutaneous prophylaxis in children, adolescents, and adults with haemophilia A at ISTH ...

A 2026 JAMA study found the Alzheimer's blood test p-tau217 predicts cognitive impairment risk up to a decade early in ...